• 04/10/2017

    The Eduardo Anitua Foundation joins the UPV / EHU as a University Institute

    The rector of the University of the Basque Country, Nekane Balluerka, and the president of the Eduardo Anitua Foundation, have signed on October 4 the agreement that officially links both entities.

  • 27/09/2017

    Aesthetic abutments for indirect restorations

    Within its constant effort to contribute to the improvement of clinical practice, BTI continues betting on the indirect restorations for their demonstrated aesthetic and functional success in the long term.

  • 19/09/2017

    Lectures by Eduardo Anitua in the United States and Japan

    Last week Dr. Eduardo Anitua has given several lectures in the United States and Japan.

  • 04/09/2017

    BTI in the Congress FDI 2017 in Madrid

    BTI has been present at the FDI World Dental Congress, held in Madrid from 29 August to 1 September. During the congress the latest news and products of BTI have been presented to the international dental community.

  • 18/08/2017

    Eduardo Anitua interviewed in the RNE radio programme "España vuelta y vuelta"

    Dr. Eduardo Anitua has been interviewed by journalist Manolo HH in the Radio Nacional de España programme "España vuelta y vuelta". Among other topics, the R & D model developed by BTI has been addressed, which has allowed it to be the biotech company with the highest scientific production in Spain for the second consecutive year.

  • 10/08/2017

    Interview with Eduardo Anitua in Vozpópuli

    Dr. Eduardo Anitua has been interviewed in the digital media Vozpópuli on the publication of the Asebio 2016 Report, which indicates BTI as the company with the highest scientific production in Spain for the second consecutive year. The interview includes, among other subjects, the history and trajectory of BTI, its molding of R & D, or its internationalization process.

Page of 35

Intended for international use only. Indications for use of products and/or therapies contained herein may not be cleared /approved for use by the following Health international agencies: US Food & Drug Administration, Health Canada or Japanese Health Ministry. To access the specific information of your market, use the country selector located on the top menu of this page.

Are you interested in contacting us?